欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Sildenafil Actavis	Human	sildenafil	sildenafil	EMEA/H/C/001090	Actavis Group PTC ehf	2009/12/10	Authorised
Lamivudine Teva Pharma B.V.	Human	lamivudine	lamivudine	EMEA/H/C/001111	Teva B.V.	2009/12/10	Authorised
Olazax Disperzi	Human	olanzapine	olanzapine	EMEA/H/C/001088	Glenmark Pharmaceuticals s.r.o.	2009/12/10	Authorised
Prevenar 13	Human	pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)	Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 3;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6A;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19A;Pneumococcal polysaccharide serotype 19F;Pneumococcal polysaccharide serotype 23F	EMEA/H/C/001104	Pfizer Europe MA EEIG	2009/12/09	Authorised
Olanzapine Glenmark Europe	Human	olanzapine	olanzapine	EMEA/H/C/001086	Glenmark Arzneimittel GmbH	2009/12/03	Authorised
Olanzapine Glenmark	Human	olanzapine	olanzapine	EMEA/H/C/001085	Glenmark Arzneimittel GmbH	2009/12/03	Authorised
Hirobriz Breezhaler	Human	indacaterol	indacaterol maleate	EMEA/H/C/001211	Novartis Europharm Limited	2009/11/30	Authorised
Zutectra	Human	human hepatitis B immunoglobulin	human hepatitis B immunoglobulin	EMEA/H/C/001089	Biotest Pharma GmbH	2009/11/30	Authorised
Nevirapine Teva	Human	nevirapine	nevirapine	EMEA/H/C/001119	Teva B.V.	2009/11/30	Withdrawn
Sildenafil Teva	Human	sildenafil	sildenafil	EMEA/H/C/001073	Teva B.V.	2009/11/30	Authorised
Oslif Breezhaler	Human	indacaterol	indacaterol maleate	EMEA/H/C/001210	Novartis Europharm Limited	2009/11/29	Authorised
Onbrez Breezhaler	Human	indacaterol	indacaterol maleate	EMEA/H/C/001114	Novartis Europharm Limited	2009/11/29	Authorised
Irbesartan/Hydrochlorothiazide Teva	Human	irbesartan;hydrochlorothiazide	irbesartan;hydrochlorothiazide	EMEA/H/C/001112	Teva B.V.	2009/11/26	Authorised
Multaq	Human	dronedarone	dronedarone	EMEA/H/C/001043	Sanofi Winthrop Industrie	2009/11/25	Authorised
Copalia HCT	Human	amlodipine;valsartan;hydrochlorothiazide	amlodipine;valsartan;hydrochlorothiazide	EMEA/H/C/001159	Novartis Europharm Limited	2009/11/03	Authorised
Dafiro HCT	Human	amlodipine besilate;valsartan;hydrochlorothiazide	valsartan;hydrochlorothiazide;amlodipine besilate	EMEA/H/C/001160	Novartis Europharm Limited	2009/11/03	Authorised
Repaglinide Krka	Human	repaglinide	repaglinide	EMEA/H/C/001066	Krka, d.d., Novo mesto	2009/11/03	Authorised
Irbesartan Teva	Human	irbesartan	irbesartan	EMEA/H/C/001093	Teva B.V.	2009/10/30	Authorised
Eporatio	Human	epoetin theta	epoetin theta	EMEA/H/C/001033	Ratiopharm GmbH	2009/10/29	Authorised
Ilaris	Human	canakinumab	Canakinumab	EMEA/H/C/001109	Novartis Europharm Limited	2009/10/23	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-